上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性，接下來我們將會繼續深入探討問題。1381Please respect copyright.ＰＥＮＡＮＡyn2rSK9QkO
1381Please respect copyright.ＰＥＮＡＮＡzsy0LTnSLp
上集：https://www.penana.com/article/4711251381Please respect copyright.ＰＥＮＡＮＡdm1DGp3JRu
1381Please respect copyright.ＰＥＮＡＮＡb16RukokCf
1381Please respect copyright.ＰＥＮＡＮＡZiHzeeJNQF
1381Please respect copyright.ＰＥＮＡＮＡPKhfljqqrZ
（圖1）雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力，但另一個重要的問題是，如何確保有足夠的T cell殺滅癌細胞呢?1381Please respect copyright.ＰＥＮＡＮＡCzGcCTPsjO
1381Please respect copyright.ＰＥＮＡＮＡrKTGVUxgYZ
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物，但免疫系統細胞數量不足的話，依然是不會達到重大效果的。1381Please respect copyright.ＰＥＮＡＮＡqcV5qWmaRh
1381Please respect copyright.ＰＥＮＡＮＡ1xVBY6X8s5
換句話說，我們需要一道能夠提升針對癌細胞的T cell數量手段。1381Please respect copyright.ＰＥＮＡＮＡhxBlPfVcwS
1381Please respect copyright.ＰＥＮＡＮＡbXT14CxkfG
1381Please respect copyright.ＰＥＮＡＮＡ8264IuEU9U
1381Please respect copyright.ＰＥＮＡＮＡOjTZIdgG34
（圖2）T cell的產生數量，接近可以說是由Antigen Presenting Cells(APC)來決定;1381Please respect copyright.ＰＥＮＡＮＡ6SntWX9GIU
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1381Please respect copyright.ＰＥＮＡＮＡPoph1uF56r
1381Please respect copyright.ＰＥＮＡＮＡqTJslf49DR
忘記甚麼是Neoantigen的話，可重溫上一集。1381Please respect copyright.ＰＥＮＡＮＡx2f2duw0Qb
1381Please respect copyright.ＰＥＮＡＮＡAj6taswQB9
當APC展示癌細胞的Neoantigen予T cell的receptor後，另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1381Please respect copyright.ＰＥＮＡＮＡgEGAUykSJ1
1381Please respect copyright.ＰＥＮＡＮＡ0oJH8fW5xi
只要兩者條件達成的話，負責對付對應癌細胞的T cell數量及效力便會大增。1381Please respect copyright.ＰＥＮＡＮＡ45fzAgKytt
1381Please respect copyright.ＰＥＮＡＮＡSTR53Ls1Yc
1381Please respect copyright.ＰＥＮＡＮＡd0n4or0vik
1381Please respect copyright.ＰＥＮＡＮＡhBa8vbIQiN
（圖3）然而，當T cell數量產生至一定程度的時候，T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置，與B7合併。1381Please respect copyright.ＰＥＮＡＮＡsOC7xqljqF
1381Please respect copyright.ＰＥＮＡＮＡmAHtVws5Q9
而當CTLA4與B7合併後，T cell所產生的數量及威力就會大減。1381Please respect copyright.ＰＥＮＡＮＡSF5UxgiyLy
1381Please respect copyright.ＰＥＮＡＮＡ8HpZGRvKdr
這個CTLA4產生的機制是與生俱來的，目的就是為了避免產生過量的T cell，以免身體會產生不良反應。1381Please respect copyright.ＰＥＮＡＮＡiLfz09oJS3
1381Please respect copyright.ＰＥＮＡＮＡHRx7gAZDxL
1381Please respect copyright.ＰＥＮＡＮＡGFSejqls0w
（圖4）只不過的是，現時癌細胞大敵當前，燃眉之急就是要調動大量的T cell前往討伐癌細胞。1381Please respect copyright.ＰＥＮＡＮＡrmJPFauTj3
1381Please respect copyright.ＰＥＮＡＮＡWH6iC6Eg6V
為此，我們重施應對PD1/PDL1故技，利用抗體阻擋CTLA4，確保CD28及B7持續合併，不斷產生效力高強的T cell。1381Please respect copyright.ＰＥＮＡＮＡSEnGlgElf7
1381Please respect copyright.ＰＥＮＡＮＡSQZacmrdJ2
1381Please respect copyright.ＰＥＮＡＮＡF4z5WY69zB
（圖5）簡略的總結來說，為了確保有足夠的T cell消滅癌細胞，我們不惜採用阻擋CTLA4的抗體，號令身體持續產生效力高強的T cell。1381Please respect copyright.ＰＥＮＡＮＡmZ9SBhOM4J
而另一邊廂，我們亦同時利用阻擋PD1/PDL1的抗體，確保T cell能夠順利把癌細胞辨認成為外來物，將其制裁。1381Please respect copyright.ＰＥＮＡＮＡhpPDm0k5LE
1381Please respect copyright.ＰＥＮＡＮＡOV9pPtXwmp
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法，將能大大提升免疫治療的效率。1381Please respect copyright.ＰＥＮＡＮＡHYXl0rhtzK
1381Please respect copyright.ＰＥＮＡＮＡIYsMEMycY5
但是，並不是所有病人也能依靠這方法而得益，原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1381Please respect copyright.ＰＥＮＡＮＡULw7Zz7fGe
1381Please respect copyright.ＰＥＮＡＮＡrrw86wQzMx
這一方面，我們將會在下一篇免疫治療的最終章再作探討。1381Please respect copyright.ＰＥＮＡＮＡKzYcgjzRvQ
1381Please respect copyright.ＰＥＮＡＮＡMAdjUDdlJm
1381Please respect copyright.ＰＥＮＡＮＡInxOSjjIaI
如果想我快啲出文的話，請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark，這對我非常之重要。1381Please respect copyright.ＰＥＮＡＮＡIPp4c2EA1V
1381Please respect copyright.ＰＥＮＡＮＡgJ543a330Z
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1381Please respect copyright.ＰＥＮＡＮＡKYDelvahor
1381Please respect copyright.ＰＥＮＡＮＡg9RCJMsLaj
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」，以課金的方式推動我繼續搜羅資料寫文，多謝。1381Please respect copyright.ＰＥＮＡＮＡaptGwT8zrs
1381Please respect copyright.ＰＥＮＡＮＡwO3jenVCGF
Link:1381Please respect copyright.ＰＥＮＡＮＡnPK3qhpCNu
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1381Please respect copyright.ＰＥＮＡＮＡGgWaO7MGVk
1381Please respect copyright.ＰＥＮＡＮＡ3pH5j7UwA5
1381Please respect copyright.ＰＥＮＡＮＡ6p4eSbLMpv
有興趣接收科普資訊的話，歡迎follow IG: potatopigtongue。1381Please respect copyright.ＰＥＮＡＮＡRmaQz9NspS
Penana
search
登入arrow_drop_down
註冊arrow_drop_down
